Delivery Order SPE2DB20D2104-SPE2DB22FQ68S
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of UROCIT-K SR 10 MEQ TABLET UU 100S. The contract, valued at $1,252.34, is a firm fixed-price delivery order with a completion date of July 29, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,524.02 and an ultimate completion date of March 4, 2025. It is a firm fixed-price contract for the supply of UROCIT-K SR 10 MEQ TABLET. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of UROCIT-K SR 10 MEQ tablets in quantities of 100 units, with a ceiling value of $5,556.57. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating full and open...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award, valued at $2,810.36, is for the supply of Potassium Citrate ER 15 MEQ tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora,...
- This federal contract award, valued at $1,111.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order to supply the product "Potassium Citrate ER 15 MEQ TB 100S" with a completion date of September 1, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
- This federal contract award is for the delivery of Potassium Citrate ER 10 MEQ TB 100S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,422.46, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with an ultimate completion date of March 24, 2022. The contract was awarded on March 23, 2022, without any set-aside designation,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,214.13, is for the delivery of Potassium Citrate ER 10 MEQ tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Potassium Chloride Extended Release 8 MEQ Tablets in quantities of 500s. The $2,346.33 firm fixed-price delivery order was placed against Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,862.84 firm-fixed-price delivery order is for the pharmaceutical product Myrbetriq ER 25 mg tablets. The contract has an ultimate completion date of October 30, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at $2,413.80. The contract provides 4,561,985,737 potassium chloride extended-release 20 milliequivalent tablets in 100-count bottles. There is no set-aside designation, indicating this was an open competition. Amerisourcebergen, a major pharmaceutical distributor, plays a critical role in supplying medical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FQ68SDelivery Order
This federal contract award, with a value of $2,811.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UROCIT-K ER 15 MEQ tablets, a medication used to treat various medical conditions. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 10/11/21 |